Uncommon manifestation of a mixed-species malaria infection: cryptic falciparum malaria in a traveler with successfully treated tertian malaria

J Travel Med. 2012 Mar-Apr;19(2):133-5. doi: 10.1111/j.1708-8305.2011.00595.x. Epub 2012 Feb 24.

Abstract

We report a case of falciparum malaria in a traveler 9 days after successful treatment of ovale malaria. The underlying, cryptic mixed-species infection was primarily undetectable with standard laboratory diagnostics. This case highlights the limitations of these tests and the unpredictability of typical incubation periods in the individual case.

Publication types

  • Case Reports

MeSH terms

  • Antimalarials / administration & dosage
  • Artemether, Lumefantrine Drug Combination
  • Artemisinins / administration & dosage*
  • Chloroquine / administration & dosage*
  • Chromatography, Affinity / methods
  • Coinfection* / blood
  • Coinfection* / drug therapy
  • Coinfection* / parasitology
  • Coinfection* / physiopathology
  • Drug Combinations
  • Drug Substitution / methods
  • Ethanolamines / administration & dosage*
  • Fluorenes / administration & dosage*
  • Germany
  • Humans
  • Infectious Disease Incubation Period
  • Malaria* / blood
  • Malaria* / drug therapy
  • Malaria* / parasitology
  • Malaria* / physiopathology
  • Male
  • Microscopy / methods
  • Middle Aged
  • Nigeria
  • Parasitemia / diagnosis
  • Plasmodium falciparum* / drug effects
  • Plasmodium falciparum* / isolation & purification
  • Plasmodium ovale* / drug effects
  • Plasmodium ovale* / isolation & purification
  • Primaquine / administration & dosage*
  • Travel*
  • Treatment Outcome

Substances

  • Antimalarials
  • Artemether, Lumefantrine Drug Combination
  • Artemisinins
  • Drug Combinations
  • Ethanolamines
  • Fluorenes
  • Chloroquine
  • Primaquine